The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.11BCNY
610.80M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue (TTM)
343.36MCNY
51.00M · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
-36.12%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Beta
0.4820x
vs all stocks
Updated Aug 20, 2026
52-Week Change
-10.09%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
4.11BCNY
610.80M · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
4.07BCNY
603.75M · vs all stocks (USD)
Updated Aug 20, 2026
Forward P/E
8.19x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Price to Sales (TTM)
12.10x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Price to Book (MRQ)
2.67x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Enterprise to Revenue
11.84x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Enterprise to EBITDA
-22.90x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Gross Margin
21.90%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 14.81%.Updated Aug 20, 2026
Profit Margin
-36.12%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Operating Margin
-51.31%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Return on Assets (TTM)
-4.89%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Return on Equity (TTM)
-7.63%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Revenue (TTM)
343.36MCNY
51.00M · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
1.65CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
-39.30%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Gross Profit (TTM)
50.85MCNY
7.55M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
-177.54MCNY
-26.37M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
-124.03MCNY
-18.42M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
-72.12%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
-94.10MCNY
-13.98M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
-30.08MCNY
-4.47M · vs all stocks (USD)
Updated Aug 20, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Minority Interest (Equity)
111.26MCNYFY2025 · Dec 31, 2025
Revenue
377.90MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
289.88MCNYFY2025 · Dec 31, 2025
Gross Profit
88.02MCNYFY2025 · Dec 31, 2025
Operating Income
-88.86MCNY
-13.20M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-147.07MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-29.52MCNYFY2025 · Dec 31, 2025
Net Income
-117.55MCNYFY2025 · Dec 31, 2025
EBIT
-142.27MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-1.94MCNYFY2025 · Dec 31, 2025
Research & Development
83.86MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
32.82MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
3.80MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
796.93KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
4.80MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.5300CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.5300CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
206.12MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
206.12MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-117.55MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
8.30MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-123.36MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-128.09MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
116.48MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-117.55MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
9.05MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-48.73MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
33.87MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-4.72MCNYFY2025 · Dec 31, 2025
Net Acquisitions
0.00CNYFY2025 · Dec 31, 2025
Purchase of Investments
-4.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
4.45MCNYFY2025 · Dec 31, 2025
Other Investing Activity
19.98MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
15.71MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
107.81MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-199.12MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-3.13MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-46.50MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-140.94MCNYFY2025 · Dec 31, 2025
Shares Outstanding
207.81MSharesUpdated Aug 20, 2026
Float Shares
130.53MSharesUpdated Aug 20, 2026
% Held by Insiders
38.63%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
1.95%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
256.64MCNY
38.12M · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
1.24CNYUpdated Aug 20, 2026
Total Debt (MRQ)
124.21MCNY
18.45M · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.0749x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Current Ratio (MRQ)
2.84x
vs Scientific & Technical Instruments peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
7.50CNYUpdated Aug 20, 2026
Total Assets
2.31BCNY
342.95M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.64BCNYFY2025 · Dec 31, 2025
Total Liabilities
623.01MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
666.28MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
22.76MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
600.25MCNYFY2025 · Dec 31, 2025
Cash
116.48MCNYFY2025 · Dec 31, 2025
Cash Equivalents
0.00CNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
116.48MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
200.02MCNYFY2025 · Dec 31, 2025
Accounts Receivable
686.43MCNYFY2025 · Dec 31, 2025
Inventory
531.37MCNYFY2025 · Dec 31, 2025
Accounts Payable
438.53MCNYFY2025 · Dec 31, 2025
Short-term Debt
110.10MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
9.66MCNYFY2025 · Dec 31, 2025
Long-term Debt
22.23MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
207.81MCNYFY2025 · Dec 31, 2025
Retained Earnings
404.96MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.69BCNY
250.42M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
20.99MCNYFY2025 · Dec 31, 2025
52-Week Low
16.00CNYUpdated Aug 20, 2026
52-Week High
35.69CNYUpdated Aug 20, 2026
52-Week Change
-10.09%
vs all stocks
Updated Aug 20, 2026
Beta
0.4820x
vs all stocks
Updated Aug 20, 2026
50-Day MA
19.45CNYUpdated Aug 20, 2026
200-Day MA
24.55CNYUpdated Aug 20, 2026
Avg 10-Day Volume
8.89MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
16.10MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
-0.6000CNYUpdated Aug 20, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 21.9%, lower than 95% of its Scientific & Technical Instruments peers (median 38.1%)Significant